Market Indices
Latest News
 |
Codexis, Inc. (CDXS) confirmed earnings release on March 11, 2026, After...
March 10, 2026 CDXS -2.00% |
| ||
| ||
| ||
|
Price Targets
Eddie Hickman from Guggenheim issued a price target of $23.00 for ZVRA on 2026-03-10 10:40:00.The adjusted price target was set to $23.00.At the time of the announcement, ZVRA...
March 10, 2026 ZVRA 21.16%
from GLJ Research issued a price target of $17.00 for ONDS on 2026-03-10 10:16:00.The adjusted price target was set to $17.00.At the time of the announcement, ONDS...
March 10, 2026 ONDS 5.03%
from H.C. Wainwright issued a price target of $17.00 for ONDS on 2026-03-10 10:16:00.The adjusted price target was set to $17.00.At the time of the announcement, ONDS...
March 10, 2026 ONDS 5.03%
Mark Hughes from Truist Financial issued a price target of $39.00 for HRTG on 2026-03-09 19:58:00.The adjusted price target was set to $39.00.At the time of the announcement,
March 9, 2026 HRTG -0.81%
Maury Raycroft from Jefferies issued a price target of $98.00 for DNTH on 2026-03-09 19:51:00.The adjusted price target was set to $98.00.At the time of the announcement, DNTH...
March 9, 2026 DNTH 6.84%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| ATPC Agape ATP Corporation | 3.14
55.45% | ||||||||||||||||||
| ZVRA Zevra Therapeutics, Inc. | 11.05
21.16% | ||||||||||||||||||
| AXTI AXT, Inc. | 46.31
20.09% | ||||||||||||||||||
| QSIAW Quantum-Si incorporated | 0.20
19.12% | ||||||||||||||||||
| TBMC Trailblazer Merger Corpor | 11.44
14.99% | ||||||||||||||||||
| MRCC Monroe Capital Corporatio | 4.78
13.96% | ||||||||||||||||||
| RBOT Vicarious Surgical Inc. | 0.50
13.64% | ||||||||||||||||||
| XFOR X4 Pharmaceuticals, Inc. | 4.69
12.89% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP 3.44%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE 6.32%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK -0.30%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN -0.85%